Copart, Inc.

CPRT Industrials · Specialty Business Services
Delayed 15 min
Last close
$28.10
Jun 29, 2026
52-week range
$28.08 — $50.11
-44% from high
Market cap
26B
Diluted basis
Dividend yield
No dividend declared
P/E
17.5
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral
RED DEEP / 100
Composite Health
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

Copart’s 2026 10-Q, as excerpted, dedicates its MD&A section to a cautionary note on forward-looking statements, rather than specific operational analysis for the quarter ended January 31, 2026. The text defines what constitutes a forward-looking statement, identifying terms such as “may,” “will,” “expect,” and “plan.” This focus on definitional boilerplate, while legally prudent, means the provided excerpt offers no immediate insight into the Company’s financial condition or results of operations for the reporting period.

The forensic accounting scores typically applied to filings are not available for this reading. Beneish’s M-Score, Beneish’s 1999 eight-ratio earnings-manipulation detector, is absent. Similarly, Altman’s Z″ — a 1968 bankruptcy-distress index — and Piotroski’s F-Score, a 9-point fundamental strength scan, are also not provided. The Fog Index — readability score; 12 = newspaper, 18+ = obfuscatory — also lacks a value. This absence means the quantitative signals typically used to flag potential accounting irregularities or readability issues are not present in this analysis.

The provided MD&A excerpt explicitly directs readers to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the 2025 Form 10-K for a fuller discussion. Instead of quarterly performance, the 10-Q excerpt focuses on the legal framework of disclosures, noting that “all statements other than statements of historical facts are statements that could be deemed forward-looking statements.” This emphasis on definitional boilerplate, rather than operational specifics, frames the quarterly filing’s immediate utility for forensic review.

Without specific operational details from the MD&A, risk factors, or quantitative forensic scores, this reading cannot assess Copart’s financial health or potential mispricing. The filing, as presented, serves more as a procedural update on forward-looking statement definitions than a substantive quarterly review. A comprehensive understanding would require the full 10-Q and the referenced 2025 10-K to glean the granular operational and financial data necessary for a complete forensic analysis.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • Mar 3, 2026
    10-Q
    Quarterly report (2026-01-31)Period: 2026-01-310
    Read →
  • Feb 19, 2026
    8-K
    Material event (2026-02-19)### Item 2.02 Results of Operations and Financial Condition The following information and the exhibit attached hereto as Exhibit 99 .1 are intended to be furnis0
    Read →
  • Jan 26, 2026
    8-K
    Material event (2026-01-23)### Item 1.01 Entry Into Material Definitive Agreements . On January 23, 2026, Copart, Inc. (“ Copart ”) entered into a Senior Revolving Credit Agreement (the “0
    Read →
  • Dec 11, 2025
    8-K
    Material event (2025-12-05)### Item 5.07 Submission of Matters to a Vote of Security Holders . Copart, Inc. (the “Company”) held its 2025 annual meeting of stockholders on December 5, 2020
    Read →
  • Oct 24, 2025
    DEF 14A
    Proxy statement (2025-12-05)0
    Read →
  • Sep 26, 2025
    10-K
    Annual report (2025-07-31)Period: 2025-07-310
    Read →
Member feature · Custom Q&A
Ask anything about CPRT's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →